Talecris Biotherapeutics GmbH Appoints Drayton Virkler as Senior Director, Investor Relations

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) announced today the appointment of Drayton Virkler as senior director of the Talecris Investor Relations department.

MORE ON THIS TOPIC